DrugsControl Media Services

News Detail

Generic drug makers start shipping copies of ADHD drug Vyvanse (lisdexamfetamine dimesylate) (02-09-2023)

Mumbai, 2 Sept 2023: Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical's drug Vyvanse (lisdexamfetamine dimesylate), which is expected to offset the ongoing shortage of the ADHD medicine in the United States.

The U.S. Food and Drug Admin......
View Details

Source : The Hindu BusinessLine
Vyvanse (lisdexamfetamine dimesylate) ADHD medicine Food and Drug Administration generic versions

Related News